Health Catalyst, Inc. ( HCAT ) NASDAQ Global Select

Cena: 3.27 ( 6.86% )

Aktualizacja 08-22 21:58
NASDAQ Global Select
Branża: Medical - Healthcare Information Services
Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna

Notowania:

Opis firmy:

Health Catalyst, Inc. zapewnia technologię i usługi analityczne i usługi dla organizacji opieki zdrowotnej. Jego oferty obejmują platformę danych i analizy, komercyjną platformę danych i analizy dla sektora opieki zdrowotnej; AI i Data Science, zapewniając integrację AI z istniejącymi narzędziami wywiadu biznesowego, zwiększając dokładność analizy; Zarządzanie zdrowiem populacji identyfikuje poprawę w kontinuum opieki, a także przydatne wytyczne dotyczące sukcesu i automatycznych przepływów pracy; transformacja finansowa zapewniająca koszty kosztów i produktywność pracy i przechwytywanie przychodów; poprawa jakości i bezpieczeństwa przy użyciu danych klinicznych i bezpieczeństwa pacjentów, analiz i usług ekspertów; oraz krajowy ekosystem danych dotyczących przywództwa i wzajemnej wymiany wiedzy w celu przekształcenia świadczenia opieki poprzez spostrzeżenia nowej generacji. Firma była wcześniej znana jako HQC Holdings, Inc. i zmieniła nazwę na Health Catalyst, Inc. w marcu 2017 r. Health Catalyst, Inc. został założony w 2008 roku i ma siedzibę w Południowym Jordanii w stanie Utah.

Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Healthcare Information Services
Zatrudnienie: 1 300
Giełda: NASDAQ Global Select
Ilość akcji w obrocie: 95.8607
Ilość akcji: Brak danych
Debiut giełdowy: 2019-07-25
WWW: https://www.healthcatalyst.com
CEO: Mr. Daniel D. Burton
Adres: 10897 South River Front Parkway
Siedziba: 84095 South Jordan
ISIN: US42225T1079
Wskaźniki finansowe
Kapitalizacja (USD) 230 121 672
Aktywa: 813 050 000
Cena: 3.27
Wskaźnik Altman Z-Score: -1.1
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 0
P/E: -2.2
Ilość akcji w obrocie: 96%
Średni wolumen: 688 003
Ilość akcji 70 373 600
Wskaźniki finansowe
Przychody TTM 302 062 000
Zobowiązania: 458 013 000
Przedział 52 tyg.: 2.515 - 9.24
Piotroski F-Score: 4
Umiarkowany (średnia jakość finansowa)
EPS: -1.5
P/E branży: 35.1
Beta: 1.325
Raport okresowy: 2025-11-05
WWW: https://www.healthcatalyst.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Ms. Linda Llewelyn Chief People Officer 364 471 1967
Mr. Jason Alger Chief Financial Officer 328 601 1984
Mr. Benjamin Landry General Counsel & Secretary of the Board 309 092 1982
Mr. Dave Ross Chief Technology Officer 0 0
Mr. Adam Brown Senior Vice President of Investor Relations and Financial Planning & Analysis 0 0
Mr. Kyle J. Salyers Chief Strategy Officer & Senior Vice President of Corporate Development 0 0
Mr. Daniel LeSueur Chief Operating Officer 0 1978
Mr. Jeffrey P. Selander Senior Vice President of International 0 0
Ms. Tarah Neujahr Bryan Chief Marketing & Communications Officer 0 0
Mr. Daniel D. Burton Chief Executive Officer & Director 0 1975
Lista ETF z ekspozycją na akcje Health Catalyst, Inc.
Symbol ETF Ilość akcji Wartość
IWM 1 648 637 6 017 524
IWN 587 453 2 144 203
DFAT 413 748 1 510 180
VTWO 344 154 1 297 460
SCHA 326 333 1 188 432
VHT 200 756 756 850
FESM 199 369 815 419
DX2D.DE 176 319 563 568
XLPE.L 176 275 48 756 593
DFAS 173 792 634 340
IWC 154 917 565 446
AVSC 131 848 485 200
R2SC.L 107 452 299 647
ZPRR.DE 107 452 346 272
R2US.L 107 452 395 423
ISMD 106 323 388 078
PRFZ 87 749 322 916
ITOT 77 963 284 563
IHF 76 553 279 418
SCHB 75 037 275 096
HTEC 71 384 0
VFVA 69 332 261 381
PSC 61 195 223 361
AVUV 58 942 216 906
GSSC 47 321 190 703
SMLF 47 129 172 021
VTWV 44 642 168 300
VVL.TO 39 829 204 886
RSSL 34 140 124 611
EES 32 122 117 245
XRSG.L 31 560 8 729 364
XRS2.DE 31 560 100 876
XRSU.L 31 560 115 195
FDHT 14 742 60 294
IWV 12 087 44 115
XSU.TO 11 766 59 769
AVUS 9 505 34 978
DFAU 9 310 33 981
UWM 6 845 24 984
URTY 5 665 20 677
VTHR 4 818 18 163
XEQT.TO 2 979 15 132
SCDS 1 629 5 945
XUU.TO 1 408 7 151
AVSU 1 134 4 173
XGRO.TO 974 4 948
XBAL.TO 448 2 277
XUH.TO 208 764
XAW.TO 176 892
HDG 82 299
XCNS.TO 35 178
XTR.TO 8 30
RTYS.L 0 23 370
SC0K.DE 0 20 477
PZW.TO 0 1 506
Wiadomości dla Health Catalyst, Inc.
Tytuł Treść Źródło Aktualizacja Link
Health Catalyst, Inc. (HCAT) Q1 2025 Earnings Call Transcript Health Catalyst, Inc. (NASDAQ:HCAT ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Jack Knight - Vice President, Investor Relations Dan Burton - Chief Executive Officer Dan LeSueur - Chief Operating Officer Jason Alger - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Jared Haase - William Blair Jessica Tassan - Piper Sandler Elizabeth Anderson - Evercore ISI Richard Close - Canaccord Genuity Daniel Grosslight - Citi Jenny Shen - BTIG Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Jeff Garro - Stephens Sarah James - Cantor Operator Welcome to the Health Catalyst First Quarter 2025 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation. seekingalpha.com 2025-05-08 11:33:27 Czytaj oryginał (ang.)
Health Catalyst (HCAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com 2025-05-07 22:30:40 Czytaj oryginał (ang.)
Health Catalyst (HCAT) Q1 Earnings Meet Estimates Health Catalyst (HCAT) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.05 per share a year ago. zacks.com 2025-05-07 22:15:35 Czytaj oryginał (ang.)
Health Catalyst Reports First Quarter 2025 Results SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. “For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric,” said Dan Burton, CEO of Health Catalyst. globenewswire.com 2025-05-07 20:03:00 Czytaj oryginał (ang.)
Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations Health Catalyst's Improvement Expertise Built on Microsoft Azure and Azure AI Foundry to Drive Reliable Insight and Sustained Outcomes for Care Providers SALT LAKE CITY , April 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a strategic partnership with Microsoft to help healthcare organizations accelerate operational, clinical, and financial performance through AI-driven innovation. The collaboration further builds on Health Catalyst's expertise with Microsoft Azure and Azure AI Foundry capabilities, equipping healthcare organizations with advanced AI solutions to accelerate time to value, enhance care delivery, and drive measurable, long-term improvement. prnewswire.com 2025-04-29 12:30:00 Czytaj oryginał (ang.)
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025 SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2025 operating results on Wednesday, May 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. globenewswire.com 2025-04-17 12:00:00 Czytaj oryginał (ang.)
Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025 AI-driven healthcare companies like Butterfly Network and Health Catalyst have all the qualities to emerge as the next big players. zacks.com 2025-04-10 20:00:34 Czytaj oryginał (ang.)
Health Catalyst Releases Data and Analytics Solution Designed for Community, Regional, and Specialty Health Systems: Health Catalyst Ignite Spark™ SALT LAKE CITY , April 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Health Catalyst Ignite Spark™, a tailored data and analytics solution built for community health systems, regional hospitals, and multi-site practices. Smaller community health systems across the U.S. are navigating shrinking margins, policy uncertainty, and rising pressure to deliver more with less. prnewswire.com 2025-04-10 12:30:00 Czytaj oryginał (ang.)
Health Catalyst: Share Price Continues To Dismiss Positive Earnings And Improved Outlook Despite a 50% drop in HCAT's stock price, the company shows significant growth, reporting $307M in revenue and $26M in adjusted EBITDA for 2024. Health Catalyst focuses on efficiency, exiting lower-margin segments, and pushing AI-driven efficiencies, aiming for improved margins and profitability in 2025. The company forecasts strong growth with 40 new platform clients in 2025 and expects $335M in revenue, trading at a significant discount compared to industry peers. seekingalpha.com 2025-03-25 17:53:55 Czytaj oryginał (ang.)
Is the Options Market Predicting a Spike in Health Catalyst (HCAT) Stock? Investors need to pay close attention to Health Catalyst (HCAT) stock based on the movements in the options market lately. zacks.com 2025-03-25 13:55:30 Czytaj oryginał (ang.)
Health Catalyst Announces ~$5 Million Stock Repurchase SALT LAKE CITY , March 11, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has repurchased shares of its common stock ("Common Stock") in an aggregate amount of approximately $5 million. These repurchased shares were acquired between March 3, 2025, and March 10, 2025, as part of Health Catalyst's existing share repurchase program approved by its board of directors on August 2, 2022, which authorized repurchases of up to $40 million of Common Stock. prnewswire.com 2025-03-11 10:30:00 Czytaj oryginał (ang.)
Signature Healthcare to Enhance Analytics by Leveraging Health Catalyst Ignite™ SALT LAKE CITY , Feb. 27, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year agreement with Signature Healthcare, an integrated healthcare delivery system serving Southeastern Massachusetts. Signature Healthcare is collaborating with Health Catalyst to integrate data resource queries and unlock referral-related data powered by Health Catalyst Ignite™, a modern data and analytics ecosystem. prnewswire.com 2025-02-27 18:05:00 Czytaj oryginał (ang.)
Health Catalyst, Inc. (HCAT) Q4 2024 Earnings Call Transcript Health Catalyst, Inc. (NASDAQ:HCAT ) Q4 2024 Earnings Call Transcript February 26, 2025 5:00 PM ET Company Participants Jack Knight - Vice President, Investor Relations Dan Burton - Chief Executive Officer Dan LeSueur - Chief Operating Officer Jason Alger - Chief Financial Officer Conference Call Participants Jared Haase - William Blair Anne Samuel - JPMorgan Jessica Tassan - Piper Sandler Sameer Patel - Evercore ISI John Pinney - Canaccord Genuity Daniel Grosslight - Citi David Larsen - BTIG Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Operator Welcome to the Health Catalyst's Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation. seekingalpha.com 2025-02-27 01:23:03 Czytaj oryginał (ang.)
Compared to Estimates, Health Catalyst (HCAT) Q4 Earnings: A Look at Key Metrics Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2025-02-26 22:00:31 Czytaj oryginał (ang.)
Health Catalyst (HCAT) Misses Q4 Earnings and Revenue Estimates Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.02 per share a year ago. zacks.com 2025-02-26 21:10:19 Czytaj oryginał (ang.)
Health Catalyst Reports Fourth Quarter and Year End 2024 Results SALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2024. globenewswire.com 2025-02-26 18:03:00 Czytaj oryginał (ang.)
Health Catalyst to Participate in Upcoming Investor Conference SALT LAKE CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the Raymond James & Associates' 46th Annual Institutional Investors Conference, in Orlando, FL. Health Catalyst will host a fireside chat presentation on Tuesday, March 4, 2025, at 1:40 p.m. globenewswire.com 2025-02-18 10:00:00 Czytaj oryginał (ang.)
Health Catalyst to Participate in Upcoming Investor Conference SALT LAKE CITY, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, and Dan LeSueur, Chief Operating Officer, will participate in the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference, in Snowbird, UT, on Tuesday, February 11, 2025. globenewswire.com 2025-01-30 10:00:00 Czytaj oryginał (ang.)
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, and data analytics. Companies at the forefront of this shift are redefining how healthcare providers manage data, deliver care, and enhance patient outcomes. marketbeat.com 2025-01-27 09:30:08 Czytaj oryginał (ang.)
OrthoNebraska Selects Health Catalyst Ignite™ to Advance Data-Driven Orthopedic Care SALT LAKE CITY , Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year partnership with OrthoNebraska, a leading provider of orthopedic care headquartered in Omaha, Nebraska. Through this partnership, OrthoNebraska will leverage Health Catalyst Ignite™, a data and analytics ecosystem supported by best-in-class cross-industry technologies, healthcare-specific data models, self-service tools, and industry expertise in one modern, scalable environment. prnewswire.com 2025-01-13 10:00:00 Czytaj oryginał (ang.)